On Peptides, FDA Staff Scientists At Odds With Advisory Panel
· forbes.com
Though FDA would normally follow a panel’s advice to move ahead with compounded peptides, it’s unclear how it will act, because FDA staff are opposed to easing access.
Peptides are popular. But experts and physicians believe they should be better regulated. (Photo by Smith Collection/Gado/Getty Images) Gado via Getty Images
A...